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Enterokinase,  a two-chain  duodenal  serine  protease,  activates  trypsinogen  by  removing  its  N-terminal
propeptide.  Due  to  a clean  cut after  the  non-primed  site  recognition  sequence,  the  enterokinase  light  chain
is frequently  employed  in  biotechnology  to separate  N-terminal  afﬁnity  tags  from  target  proteins  with
authentic  N-termini.  In order  to  obtain  large  quantities  of this  protease,  we  adapted  an  in  vitro  folding  pro-
tocol  for a pentahistidine-tagged  triple  mutant  of the  bovine  enterokinase  light  chain.  The  puriﬁed,  highlyeywords:
iotechnology
nteropeptidase
nclusion bodies
n vitro folding
active  enzyme  successfully  processed  recombinant  target  proteins,  while  the  pentahistidine-tag  facili-
tated post-cleavage  removal.  Hence,  we  conclude  that  producing  enterokinase  in  one’s  own  laboratory
is an  efﬁcient  alternative  to the  commercial  enzyme.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.erine proteases
. Introduction
Mammalian enterokinase (EK) (EC 3.4.21.9, MEROPS identi-
er S01.156), also known as enteropeptidase, is a serine protease
ound in the brush border membrane of duodenal enterocytes
Imamura and Kitamoto, 2003). It removes the N-terminal propep-
ide from trypsinogen, thus releasing trypsin (Yamashina, 1956).
ince trypsin in turn activates a range of digestive enzymes, con-
enital EK deﬁciency leads to severe intestinal malabsorption
Holzinger et al., 2002). The EK zymogen from Bos taurus (UniProt
ccession P98072) comprises a 115 kDa single chain. Duodenase
leaves this proform between Lys800 and Ile801, which yields an N-
erminal heavy chain and a C-terminal light chain (Zamolodchikova
t al., 2000). These chains remain covalently linked by a disulﬁde
ond. The multidomain heavy chain anchors EK in the cell mem-
rane and thereby increases its speciﬁcity for trypsinogen (Lu et al.,
997). The light chain contains a single protease domain belonging
Abbreviations: BENAC, benzamidine afﬁnity chromatography; EK, enterokinase;
ST, glutathione-S-transferase; IB, inclusion body; IEC, ion exchange chromatogra-
hy;  IMAC, mmobilized metal ion afﬁnity chromatography; KLK, kallikrein-related
eptidase; SUMO, small ubiquitin-like modiﬁer; TEV, tobacco etch virus; uPA,
rokinase-type plasminogen activator.
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Open access under CC BY-NC-ND to the chymotrypsin fold (Lu et al., 1999). It retains its activity and
in vitro substrate speciﬁcity after separation from the heavy chain
(Light and Fonseca, 1984) or heterologous expression (Collins-Racie
et al., 1995; Vozza et al., 1996).
The trypsinogen propeptide harbors a sequence of four aspar-
tates followed by a single lysine (P5-DDDDK-P1, applying the
Schechter and Berger, 1967 nomenclature), which form the canon-
ical EK recognition sequence. At least two structural determinants
of the EK substrate binding site account for this unique speciﬁcity:
On the one hand, Asp189 and Ser190 (chymotrypsinogen number-
ing scheme is used throughout the text for residues of the EK light
chain) optimize the S1 pocket for recognition of lysine side chains
(Lu et al., 1999; Sichler et al., 2002). On the other hand, the KRRK
motif in the 99-loop confers a positive charge to the S2 and S4
pocket, which formally complements the charge of the carboxylate
groups of the tetra-aspartate sequence (Lu et al., 1999; Schöpfel
et al., 2011). Unlike the narrow nonprimed-site speciﬁcity, EK is
relatively promiscuous on the primed sites, accepting a wide range
of residues in the P1′ and P2′ position (Hosﬁeld and Lu, 1999).
Its ability to cut cleanly after the P1 residue and commercial
availability have rendered the EK light chain a hardy perennial in
preparative protein biochemistry, where it is frequently used to
separate an afﬁnity tag from a target protein (Young et al., 2012).
Microgram quantities of EK may  enable the puriﬁcation of suf-
ﬁcient amounts of target protein for functional studies (Debela
et al., 2006). However, the puriﬁcation of target proteins on a scale
suitable for X-ray crystallography often consumes correspondingly
large amounts of EK, sometimes up to the milligram range. Conse-
quently, structural biology laboratories may  face signiﬁcant costs
license.
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Table 1
PCR primers used for cloning pET-15b-EK C122S His5. Restriction sites are underlined.
Primer Sequence (5′ to 3′) Restriction site
1F TATAGGGGACATATGTATATCTCCTTC n/a
1R  GATGACGACGACAAGATTGTCGG n/a
2F  GCTAATAGGCTGTATATAATCTGTGTAG n/a
AACTT
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w2R  TTACCAGAAGAAAATCAAGTTTTTC 
3F  ATGCCTCGAGCTAATGATGATGATGATGTAGAA
3R  ATGCCCATGGGCCCTATAGATGACGACGACAAG
hen buying EK from commercial suppliers (Fong et al., 2010).
urthermore, downstream applications sensitive to contaminating
roteins demand that even traces of EK are removed following the
leavage reaction. Removal commonly proceeds via resin-coupled
ntibodies and precludes reuse of either EK or resin. In order to
vercome these limitations, we set out to establish an EK expression
nd puriﬁcation protocol that should (1) yield amounts sufﬁcient
or routine structural biology work, (2) facilitate post-digestion
emoval of the protease and (3) require a reasonable number of
orking hours.
. Materials and methods
.1. Materials
Enzymes and gel markers were purchased from Thermo Sci-
ntiﬁc (Waltham, MA,  USA). The pET-41a-GST EK vector, which
ncodes Chinese Northern Yellow Bovine EK with an N-terminal
ST-tag (Tan et al., 2007), was kindly provided by Haidong Tan.
z-PFR-pNA, Suc-AAPR-pNA and Tos-GPR-pNA were obtained from
achem (Weil am Rhein, Germany), Chromozym X (Mc-D-Nle-
R-pNA) was bought from Roche (Grenzach-Wyhlen, Germany).
ecombinant porcine EK was provided by GenScript (Piscataway,
J, USA). Chromatography resins were obtained from GE Health-
are (Uppsala, Sweden). Chemicals, of the highest purity available,
ere either from Merck (Darmstadt, Germany), AppliChem (Darm-
tadt, Germany) or Sigma–Aldrich (St. Louis, MO,  USA).
.2. Cloning
Plasmid pET-15b-EK C122S His5 was prepared from pET-41a-
ST EK by three steps of round-the-horn site-directed mutagenesis
Moore, 2012). First, primers 1F and 1R (Table 1) removed the
equence encoding the GST-tag. Second, primers 2F and 2R
ntroduced a C122S mutation. Finally, primers 3F and 3R gener-
ted an insert that was cloned between the Nco I and Xho I sites
f pET-15b. PCR was conducted on a Mastercycler ep gradient
Eppendorf; Hamburg, Germany). Sequencing at Euroﬁns MWG
Ebersberg, Germany) conﬁrmed that each clone was correct. pET-
5b-EK C122S His5 is available from Addgene (ID 49048).
.3. Protein expression
E. coli BL21(DE3) cells transformed with the pET-15b-
K C122S His5 plasmid were grown over-night in 200 mL LB
edium supplemented with 100 g/mL ampicillin. Twelve shakers
ith 600 mL  culture were inoculated 1:40 (v/v) with the preculture
nd grown (37 ◦C, 230 rpm) until an OD600 of 1.2 was reached. Pro-
ein expression was induced with 0.5 mM IPTG for 4 h at 37 ◦C. Cells
ere harvested by centrifugation (15 min, 4000 × g, 4 ◦C).
.4. Inclusion body isolationHarvested cells were resuspended in 50 mM Tris pH 7.0 (30 mL
uffer per 10 g cell paste) and lyzed by sonication (3 min  × 5 min
ith 50% duty time and 95% power, interrupted by chilling on ice forn/a
TGTATCCACTCT Xho I
Nco I
at least 5 min). Insoluble matter was  washed twice with 50 mM Tris
pH 7.0, 500 mM  NaCl, 20 mM EDTA, 2% (v/v) Triton X-100, and once
with 50 mM Tris pH 7.0, 20 mM EDTA. The washed IBs were solubi-
lized 1:20 (w/v) in 7.5 M guanidine-HCl pH 9, 50 mM Tris, 100 mM
-mercaptoethanol for 24 h. After adjusting the pH to 3.5–4, the
solution was dialyzed against 5 mM citrate pH 3.5–4.0. Precipitate
was collected by centrifugation (20 min, 18 000 × g, room temper-
ature) and solubilized 1:10 (w/v) in 7.5 M guanidine-HCl, 50 mM
Tris pH 4.0–4.5 for several hours.
2.5. In vitro folding
In vitro folding was initiated by dropwise dilution of the IB
solution into the 100-fold volume of 500 mM arginine, 50 mM
Tris, 20 mM CaCl2, 1 mM EDTA, 5 mM cysteine-HCl, 0.5 mM cys-
tine (from a 400 mM  cystine stock dissolved in 2 M HCl), pH 8.3 at
room temperature (Rudolph and Lilie, 1996; Zögg and Brandstetter,
2009). After 72 h at 16 ◦C, the solution was  concentrated 20-fold
either by tangential ﬂow ﬁltration (Centramate; Pall; Port Wash-
ington, NY, USA) or by dialysis against PEG 35000. For the latter
protocol, several dialysis tubes (35 mm diameter, molecular weight
cutoff 10 kDa) containing the in vitro folding solution were incu-
bated in PEG 35000 ﬂakes for at most 16 h at 4 ◦C. The concentrate
was dialyzed against 50 mM Tris pH 7.5, 50 mM NaCl. Precipitate
was removed by centrifugation (43 000 × g, 20 min, room temper-
ature) and ﬁltration (membrane pore size: 0.2 m).
2.6. Protein puriﬁcation
The protein solution was loaded onto a Q sepharose column
equilibrated in IEC buffer (50 mM Tris–HCl, pH 7.5) for negative
puriﬁcation. The ratio of load to resin was about 50:1 (v/v) in this
and all following chromatography steps. The ﬂow-through con-
tained about 75% of correctly folded EK as shown by SDS-PAGE.
The remainder was eluted from the column with 3 resin volumes
of IEC buffer supplemented with 150 mM NaCl.
IEC was  followed by either BENAC or IMAC. In the ﬁrst case,
ﬂow-though and elution from IEC were combined and brought
to 500 mM NaCl. The solution was  loaded onto a benzamidine
sepharose column equilibrated in BENAC buffer (50 mM Tris–HCl,
500 mM NaCl, pH 7.5). After washing with 8 resin volumes of BENAC
buffer, bound EK was  eluted with 3 × 2.5 resin volumes of BENAC
buffer supplemented with 25, 50 and 100 mM benzamidine, respec-
tively.
In the second case, ﬂow-though and elution from IEC were com-
bined and brought to 500 mM NaCl, 10 mM imidazole. The solution
was loaded onto a Ni2+ sepharose column equilibrated in IMAC
buffer (50 mM Tris–HCl, 500 mM NaCl, 10 mM  imidazole, pH 7.5).
After washing with 8 resin volumes of IMAC buffer, bound EK was
eluted with 3 × 2.5 resin volumes of IMAC buffer supplemented
with 250 mM imidazole.
The BENAC or IMAC eluates were concentrated to 80–100 g/mL
in Amicon Ultra-15 Centrifugal Filter Units, molecular weight cut-
off 10 kDa (Millipore; Billerica, MA,  USA), while the buffer was
exchanged to 50 mM Tris pH 7.5, 50 mM NaCl, 10% (v/v) glycerol.
EK aliquots were stored at −80 ◦C.
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fig. 1. Scheme of the EK production workﬂow. Protein production can be modularly
rganized with possible break points indicated by an hourglass symbol.
An overview of the EK production workﬂow is given in Fig. 1.
.7. Kinetic measurements
EK activity was measured in 100 L buffer (50 mM Tris–HCl
H 7.5, 50 mM NaCl, 10% (v/v) DMSO) containing 800 ng (300 nM)
nzyme and 500 M chromogenic substrate. Time-dependent sub-
trate cleavage corresponded to changes in absorbance at 405 nm.
rotein concentrations were determined by absorbance at 280 nm,
sing computed extinction coefﬁcients and molecular weights. Pro-
ein substrates were digested by EK in 50 mM Tris pH 8.0, 250 mM
aCl. Molar ratios of EK to target protein were varied. Digestion
eactions proceeded for 15 h at room temperature and were mon-
tored by SDS-PAGE.
. Results and discussion
.1. Protein production
In general, prokaryotes fail to express serine proteases belong-
ng to the chymotrypsin fold in a soluble form. Such proteins
ontain several cysteines, which refuse to form disulﬁde bonds
n the reducing environment of the prokaryotic cytosol (Rudolph
nd Lilie, 1996). Still, several groups have reported that E. coli cells
xpress the EK light chain in a soluble form if it is fused to an N-
erminal partner such as thioredoxin (Yuan and Hua, 2002), GST
Tan et al., 2007) or protein disulﬁde isomerase (Chun et al., 2011).
owever, in our hands, expression of GST-tagged EK yielded mostly
Bs. Negligible amounts of the protein were soluble, yet inactive.
urthermore, these IBs resisted refolding, most likely due to the
arge N-terminal fusion partner that was unable to fold sponta-
eously. All in all, we consider prokaryotic expression of soluble
K an inherently difﬁcult approach. This approach is presumably
ighly sensitive to external variables such as the choice of expres-
ion medium, expression levels, or the overall oxidation state. By
ontrast, chymotrypsin-related proteases are promising candidates
or in vitro folding by dialysis or dilution. Therefore, we decided toology 168 (2013) 421– 425 423
apply an in vitro folding protocol well-established for coagulation
factors (Zögg and Brandstetter, 2009) to EK IBs after overexpression.
Our newly designed construct EK C122S His5 comprised the
following elements: (1) an N-terminal artiﬁcial propeptide
(MGPIDDDDK), which contained an EK recognition sequence that
facilitated autoactivation; (2) the light chain of bovine EK from Ile16
to His243 containing the mutations P92R, E185D and C122S; the
latter mutation eliminated a surface cysteine, which in full-length
EK forms a disulﬁde bond with the heavy chain; the mutations
P92R and E185D presumably represent the EK variant that natu-
rally occurs in the Chinese Northern Yellow breed, with no reported
effect on enzymatic activity, consistent with their solvent-exposed
position (Tan et al., 2007); and (3) four additional histidine residues
at the C-terminus, which constituted a pentahistidine tag together
with His243. This tag facilitated post-cleavage removal via IMAC.
Since its afﬁnity to a metal ion resin was sufﬁcient, we did not add
a sixth histidine to the tag in order to further enhance its afﬁnity
(Knecht et al., 2009). Following in vitro folding and autocatalyzed
activation, monomeric EK C122S His5 was  separated from incor-
rectly folded and aggregated species via negative IEC followed by
either BENAC or IMAC (Fig. 2A and B). We  considered the latter two
puriﬁcation techniques equivalent, since either technique resulted
in protein that was  more than 95% pure. We also successfully tested
a BENAC-only puriﬁcation protocol (cf. Fig. 2A). However, removal
of soluble aggregates with IEC increased chromatography ﬂow rates
and the lifespan of the benzamidine-coupled resin. The ﬁnal yield of
properly folded, monomeric and active EK was  several milligrams
per liter of bacterial culture, corresponding to approximately 0.1%
(w/w) of solubilized IBs (Table 2). EK was routinely concentrated to
80–100 g/mL and stored at temperatures of −20 ◦C (short term) or
−80 ◦C (long term). Nevertheless, the peptidase resisted autodegra-
dation for several weeks even when stored at room temperature
(Fig. 2C) and was stable at up to 5 mg/mL. In total, EK production
consumed 15–20 working hours over a period of about eight days.
The preparation procedure can be interrupted after steps 1, 2 and
3 without compromising the preparation quality or yield (Fig. 1).
3.2. Enzymatic activity against small-molecule substrates and
proteinaceous targets
Although EK has been reported to be relatively speciﬁc for the
recognition sequence DDDDK↓ (Kim et al., 2008; Maroux et al.,
1971), EK C122S His5 cleaved several chromogenic substrates with
arginine instead of lysine in P1 and lacking any acidic non-primed
residues. Its speciﬁc activities against these substrates were simi-
lar to the values measured with commercially available porcine EK
(Fig. 3A). Differences, as observed for Chromozym X, may  result
from N-glycosylation of the yeast-expressed porcine enzyme at
Asn75, Asn113 and Asn175 (Vozza et al., 1996), which was absent
in refolded EK. As anticipated, the protease selectively cleaved
artiﬁcial propeptides containing an EK recognition sequence from
human KLK4 and from the -chain of uPA (Fig. 3B and C). In the
case of KLK4, a molar ratio of 1:1000 (EK to KLK4) ensured com-
plete cleavage of the target protein within 15 h. This observation
demonstrates the high proteolytic efﬁciency of EK, since milligram
amounts may  cleave grams of recombinant protein.
Important alternatives to EK include TEV and SUMO protease.
At ﬁrst sight, these enzymes overcome the potential drawbacks
of EK, namely its intricate preparation and occasional unspeciﬁc
cleavages. Soluble, high-yield expression in E. coli followed by
simple puriﬁcation has been reported for both TEV (Berg et al.,
2006) and SUMO protease (Reverter and Lima, 2009). TEV pro-
tease exclusively cuts at the sequence P6-ExxYxQ↓G/S (Tözsér
et al., 2005). SUMO protease recognizes the tertiary structure of
the SUMO tag instead of a linear epitope and cleaves C-terminal of
a conserved diglycine motif (Malakhov et al., 2004). Nonetheless,
424 W. Skala et al. / Journal of Biotechnology 168 (2013) 421– 425
Fig. 2. Puriﬁcation of EK and stability of the enzyme. (A) BENAC and (B) IMAC of EK C122S His5 after in vitro folding and autoactivation. L, load; F, ﬂow-through; W1 and
W2,  washes; E1–3, elutions; M,  molecular mass marker. All SDS-PAGE samples were prepared and run under nonreducing conditions. (C) EK stability during storage for 32
days  at room temperature as judged from its activity against Bz-PFR-pNA.
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epresents the mean of three measurements. (B) KLK4 was  incubated without EK 
ncubated with EK at a molar ratio of 1:500. All SDS-PAGE samples were prepared u
ne should stay aware of putative pitfalls associated with these
roteases: Efﬁcient processing by TEV protease requires reducing
uffer conditions and sometimes a molar ratio of 1:10 or higher.
n addition, -branched side chains in P1′ (especially isoleucine
nd valine) strongly interfere with digestion (Kapust et al., 2002).
his limitation renders TEV protease impractical for the activation
f chymotrypsin-like serine proteases, which generally require an
soleucine, leucine or valine at their mature N-terminus (Song et al.,
002). The large SUMO tag (about 100 residues) might decrease
n vitro folding yields if its ability to fold spontaneously is restricted
n the optimal refolding buffer for the target protein. By contrast,
he shortest EK-removable tag is the eight-residue FLAG tag with
ts internal EK cleavage site, which lacks secondary structure (Hopp
t al., 1988). Moreover, the active site cysteine of SUMO protease
able 2
ields during puriﬁcation of EK C122S His5. Step numbers refer to Fig. 1.
Step Amounta
1 Cell pellet wet weight 35 ± 4 g 
2  IBs (after third wash) 18 ± 2 g 
2  IBs (after dialysis against citrate buffer) 16 ± 1 g 
6  BENAC eluate 28 ± 8 mg 
7  Final product 12 ± 3 mg 
a Mean values and standard deviations from three folding experiments.
b Relative to weight of solubilized IBs (after dialysis against citrate buffer).activities of EK C122S His5 and porcine EK (GenScript, Piscataway, NJ). Each value
 with the protease at molar ratios ranging from 1:250 to 1:4000. (C) pro-uPA was
nonreducing conditions. M,  molecular mass marker.
as well as TEV (or prescission) protease typically requires 1–2 mM
dithiothreitol in the cleavage buffer (Peroutka et al., 2011), com-
plicating the tag-removal from cysteine-containing target proteins,
e.g., chymotrypsin-like proteases. Intriguingly, relying on the struc-
ture of the SUMO tag constitutes the main advantage of SUMO
protease as well as its major drawback with respect to EK. On the
one hand, exclusive recognition of an intact tertiary structure con-
fers absolute substrate speciﬁcity to SUMO protease. On the other
hand, this peculiarity renders SUMO protease markedly suscepti-
ble to a range of detergents (Vergis and Wiener, 2011). Hence, it
will refuse to process most SUMO-tagged recombinant membrane
proteins, which commonly require detergents to remain soluble
during puriﬁcation. In contrast, chymotrypsin-related serine pro-
teases like EK, thrombin and factor Xa retain their activity even in
Yield (per L culture)a Yield (%)b
4.9 ± 0.5 g –
2.6 ± 0.2 g –
2.2 ± 0.1 g 100
3.9 ± 1.1 mg 0.2
1.7 ± 0.4 mg  0.1
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etergent-containing buffers. Taken together, commonly used pro-
eases like SUMO, TEV, or prescission are complementary rather
han alternative tools to EK in the protein engineering box.
. Conclusion
In summary, we expressed pentahistidine-tagged EK in E. coli
nd refolded the protein from bacterial IBs. Puriﬁed EK speciﬁcally
leaved N-terminal tags from recombinant target proteins. Thus,
e conclude that despite the emergence of other highly speciﬁc
roteases, do-it-yourself EK will remain an essential tool for protein
iochemists.
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